Global Scans · Brain Technologies · Weekly Summary

• [New] Elon Musk's Neuralink will commence a clinical trial for its human brain implant in the US in October. Notebookcheck
• [New] Neuralink plans an October clinical trial to convert thoughts into text for speech-impaired individuals, building on its brain implants for paralysis patients. WebProNews
• [New] Neuralink Corp., Elon Musk's brain implant company, plans to launch a clinical trial in the US in October aiming to use its device to translate thoughts into text, potentially opening up new possibilities for speech-impaired people to communicate. Bloomberg
• Elon Musk's brain implant start-up, Neuralink, plans to launch a US clinical trial next month of a device that it says can translate thoughts into text. PCMAG
• Elon Musk's brain implant company Neuralink is preparing to launch a new clinical trial in the U.S. in October 2025 that will focus on reading speech from thoughts. TeslaNorth.com
• The acceleration of human trials by CIBR and NeuCyber could make Beinao No.1 the brain chip with the highest number of patients in the world, underlining China's determination to catch up with leading foreign BCI developers. Blogger
• Neuralink's upcoming trial represents a revolutionary step in brain-computer interfaces, offering hope to patients with severe speech and motor impairments. The Times Of India
• In just a year, AI technologies advanced faster than expected: large models evolved into intelligent agents, lightweight open-source models lowered entry barriers, and breakthroughs like brain-computer interfaces drew closer. Geopolitechs
• AI, machine learning, and the brain-computer interface will undoubtedly have a dramatic effect on battlefields of the future, and hence potentially on global balances of power. The European Financial Review
• Internal roadmap documents suggest even more revolutionary products planned for 2026 and 2027, including augmented reality glasses, autonomous vehicle technology, and brain-computer interface research. Axis Intelligence
• Alzheimer's disease is a progressive brain disorder and the most common cause of dementia, affecting approximately 7.2 million adults aged 65 and older in the United States as of 2025, a number expected to nearly double by 2050. Los Altos Neurology
• Non-invasive brain health devices that are portable, clinic-ready, and safe will remain the opening to accessibility for the next decade. BusinessLine
• Australian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug suppresses tumour activity and provides hope to patients with low-grade gliomas. ecancer
• Elon Musk's brain-tech company Neuralink is laying out a bold path forward, forecasting a massive expansion that would see it implant brain chips in 20,000 people each year by 2031. stupidDOPE
• Critical 2026 milestones include standardized neuromorphic benchmarks through IEEE P2800, mass production of neuromorphic microcontrollers at > = 100,000 units per year scale, and first medical device approvals for neuromorphic-powered seizure prediction and continuous health monitoring wearables. Quick Market Pitch
• Neuromorphic chips will be present in 40% of IoT sensor nodes by 2030, driven by edge processing requirements and power efficiency demands. Quick Market Pitch
• Companies like Neuralink are making significant progress in developing brain-machine interfaces, aiming for practical applications by 2035. TouchstoneTruth.com
• Emerging regions such as Latin America and the Middle East & Africa represent high growth potential for brain implants. https://exactitudeconsultancy.com/
• The digital natives who have no memory of a world without the internet and social media are going to find themselves competing with AI natives, who cannot conceive of a time without an external brain and digital adviser. American Enterprise Institute - AEI
• The study, called GB-PRIME, will test a Brain Computer Interface (BCI). MND Association

Last updated: 12 October 2025